New York State Teachers Retirement System (NYSTRS)
EGRX

New York State Teachers Retirement System (NYSTRS)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

New York State Teachers Retirement System (NYSTRS)’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18,017
Closed -$511K – 1643
2023
Q1 		$511K Sell
18,017
-400
-2% -$11.9K ﹤0.01% 1405
2022
Q4 		$538K Hold
18,417
– – ﹤0.01% 1395
2022
Q3 		$487K Hold
18,417
– – ﹤0.01% 1395
2022
Q2 		$818K Hold
18,417
– – ﹤0.01% 1315
2022
Q1 		$911K Sell
18,417
-100
-0.5% -$4.8K ﹤0.01% 1320
2021
Q4 		$943K Buy
18,517
+100
+0.5% +$5.18K ﹤0.01% 1321
2021
Q3 		$1.03M Hold
18,417
– – ﹤0.01% 1316
2021
Q2 		$788K Hold
18,417
– – ﹤0.01% 1349
2021
Q1 		$769K Sell
18,417
-500
-3% -$23.2K ﹤0.01% 1359
2020
Q4 		$881K Hold
18,917
– – ﹤0.01% 1311
2020
Q3 		$804K Sell
18,917
-200
-1% -$8.75K ﹤0.01% 1276
2020
Q2 		$917K Sell
19,117
-191
-1% -$9.53K ﹤0.01% 1227
2020
Q1 		$888K Hold
19,308
– – ﹤0.01% 1149
2019
Q4 		$1.16M Buy
19,308
+9,631
+100% +$574K ﹤0.01% 1217
2019
Q3 		$547K Hold
9,677
– – ﹤0.01% 1351
2019
Q2 		$539K Hold
9,677
– – ﹤0.01% 1343
2019
Q1 		$489K Buy
9,677
+208
+2% +$9.26K ﹤0.01% 1372
2018
Q4 		$382K Buy
9,469
+43
+0.5% +$2.22K ﹤0.01% 1393
2018
Q3 		$654K Buy
9,426
+711
+8% +$53.9K ﹤0.01% 1351
2018
Q2 		$659K Sell
8,715
-1,200
-12% -$75.5K ﹤0.01% 1356
2018
Q1 		$522K Buy
9,915
+1,200
+14% +$69.8K ﹤0.01% 1393
2017
Q4 		$466K Buy
8,715
+158
+2% +$8.79K ﹤0.01% 1421
2017
Q3 		$510K Sell
8,557
-2,200
-20% -$133K ﹤0.01% 1390
2017
Q2 		$849K Buy
10,757
+800
+8% +$65.4K ﹤0.01% 1297
2017
Q1 		$826K Hold
9,957
– – ﹤0.01% 1312
2016
Q4 		$790K Buy
9,957
+200
+2% +$14.5K ﹤0.01% 1334
2016
Q3 		$683K Buy
+9,757
New +$541K ﹤0.01% 1343
2016
Q2 		– Sell
-700
Closed -$28K – 1679
2016
Q1 		$28K Buy
+700
New +$44.4K ﹤0.01% 1629

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)'s EGRX Position: Q2 2023 in Review

New York State Teachers Retirement System (NYSTRS) sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2023, closing a stake of 18,017 shares — an estimated $511K sold.

New York State Teachers Retirement System (NYSTRS) first reported a position in EGRX in Q1 2016 and held it in 28 quarters. The position peaked at $1.16M in Q4 2019. 126 funds tracked by Wall St. Rank hold EGRX as of Q2 2023.

  • New York State Teachers Retirement System (NYSTRS) reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • New York State Teachers Retirement System (NYSTRS) sold 18,017 Eagle Pharmaceuticals, Inc. shares in Q2 2023, an estimated $511K.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2016 and held it in 28 quarters.
  • New York State Teachers Retirement System (NYSTRS)'s Eagle Pharmaceuticals, Inc. position peaked at $1.16M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2023.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2023, filed 27 Jul 2023.